Here are five highlights:
1. The OsteoCool System is the only cooled radiofrequency ablation technology that offers simultaneous, dual-probe capabilities, providing procedural flexibility and predictable, customized treatment.
2. Cooled RF ablation uses targeted high-frequency energy to destroy cancer cells.
3. This device can be used on patients with painful spine metastases.
4. Metastatic bone disease has been reported to occur in 60 percent to 80 percent of cancer patients, most frequently among patients with primary malignancies of the breast, prostate, liver and lung.
5. Seventy percent of metastatic bone cancer patients develop at least one lesion in the spine.
More articles on devices and implants:
21 spine devices receive FDA 510(k) clearance in December
Intellijoint Surgical wins Frost & Sullivan award for enabling technology leadership: 3 things to know
Forbes names Vertera Spine Founder Allen Chang to ’30 under 30′ list: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
